Generic Name and Formulations:
Epinephrine (as HCl) 1mg/mL; soln for IM or SC inj; contains sulfites.
Par Pharmaceutical, Inc.
Indications for ADRENALIN:
Emergency treatment of allergic reactions (Type I), including anaphylaxis. Bronchospasm. Urticaria. Angioedema. Serum sickness.
Adults and Children:
Do not dilute. Inject into the anterolateral aspect of the thigh. ≥30kg: 0.3–0.5mg SC or IM; max: 0.5mg per inj. <30kg: 0.01mg/kg SC or IM; max: 0.3mg per inj. Both: may repeat every 5–10 mins as necessary; rotate inj sites. Monitor clinically for reaction severity and cardiac effects.
Avoid injecting into the buttocks, digits, hands, or feet. Cardio or cerebrovascular disease. Hypertension. Diabetes. Hyperthyroidism. Parkinson's disease, Pheochromocytoma. Elderly. Pregnancy (Cat.C). Labor & delivery. Nursing mothers.
Additive effects with concomitant other sympathomimetic agents. Caution with cardiac glycosides, digitalis, diuretics, quinidine, and other arrhythmia-producing agents; monitor. Pressor effects may be potentiated by tricyclic antidepressants, MAOIs, antihistamines, levothyroxine. May be antagonized by α-blockers (eg, phentolamine), β-blockers (eg, propranolol), ergots. Caution with halogenated hydrocarbon general anesthetics (eg, halothane). Do not use to counteract effects of phenothiazines.
Anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea, vomiting, headache, respiratory difficulties, angina, arrhythmias, ventricular fibrillation (may be fatal), rapid rises in BP, cerebral hemorrhage; rare: serious infections at the inj site.
Single-dose vials (1mL)—25; Multi-dose vials (30mL)—1, 10
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|